{"id":9676,"date":"2024-02-26T06:00:00","date_gmt":"2024-02-26T05:00:00","guid":{"rendered":"https:\/\/www.icta.fr\/?p=9676"},"modified":"2024-02-29T16:57:01","modified_gmt":"2024-02-29T15:57:01","slug":"journee-de-la-recherche-clinique-icta-animera-pour-le-compte-de-lafcros-la-table-ronde-1-dediee-aux-enjeux-financiers-et-strategiques-des-biotechs-et-medtechs","status":"publish","type":"post","link":"https:\/\/www.icta.fr\/fr\/journee-de-la-recherche-clinique-icta-animera-pour-le-compte-de-lafcros-la-table-ronde-1-dediee-aux-enjeux-financiers-et-strategiques-des-biotechs-et-medtechs\/","title":{"rendered":"12\u00e8me Journ\u00e9e de la Recherche Clinique &#8211; ICTA animera une table ronde 1 d\u00e9di\u00e9e aux enjeux financiers et strat\u00e9giques des biotechs et medtechs"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n<p><strong>Vous \u00eates Biotech, Medtech ou Healthtech ? Vous d\u00e9veloppez des produits de sant\u00e9 innovants ?<\/strong><\/p>\n<p>Rejoignez-nous alors \u00e0 la <strong>12<sup>\u00e8me<\/sup> Journ\u00e9e de la recherche Clinique <\/strong>le<strong> 14 mars prochain<\/strong> autour de <strong>la table ronde 1<\/strong> sur la th\u00e9matique :<\/p>\n<p style=\"text-align: center;\"><strong>Biotech \/ Medtech<br \/>Enjeux et strat\u00e9gies de financement : Impact et adaptation des plans de d\u00e9veloppement clinique<\/strong><\/p>\n<p>Des repr\u00e9sentants de biotech, de soci\u00e9t\u00e9s d\u2019investissement, de l\u2019association France Biotech et de CRO vous apporteront leurs points de vue et partageront leurs exp\u00e9riences, notamment\u00a0sur\u00a0:<\/p>\n<p><!-- \/wp:post-content --><!-- wp:paragraph {\"kioblocks\":[]} --><\/p>\n<p><!-- wp:paragraph {\"kioblocks\":[]} --><\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<ul>\n<li>l\u2019\u00e9laboration des strat\u00e9gies de d\u00e9veloppement clinique et de valorisation de vos produits<\/li>\n<li>les solutions \u00e0 mettre en place pour s\u00e9curiser le risque des plans de d\u00e9veloppement et rassurer les investisseurs<\/li>\n<li>les perspectives pour les d\u00e9veloppements cliniques de vos mol\u00e9cules, dispositifs et autres produits sur le territoire fran\u00e7ais, europ\u00e9en et outre atlantique.<\/li>\n<\/ul>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph {\"kioblocks\":[]} --><\/p>\n<p><!-- wp:paragraph {\"kioblocks\":[]} --><\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<p><!-- wp:paragraph {\"kioblocks\":[]} --><\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<p><!-- wp:paragraph {\"kioblocks\":[]} --><\/p>\n<p>La table ronde sera anim\u00e9e par Remi Gauchoux, AFCROs qui sera entour\u00e9 de Val\u00e9rie Calenda (M\u00e9rieux Equity Partners), Franck Mouthon (France Biotech), Guillaume Van Renterghem (LifeSci Advisors), Yann Godfrin (Axoltis) et Christophe Cl\u00e9ment (ICTA).<\/p>\n<p><strong>RESERVEZ <\/strong>d\u00e8s \u00e0 pr\u00e9sent<strong> LE 14 MARS 2024<\/strong> dans votre agenda et inscrivez-vous au plus vite:<\/p>\n<p><a href=\"https:\/\/journee-recherche-clinique.fr\/\" target=\"_blank\" rel=\"noopener\">https:\/\/journee-recherche-clinique.fr\/<\/a><\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<p><!-- wp:paragraph {\"kioblocks\":[]} --><\/p>\n<p><!-- \/wp:paragraph --><\/p>","protected":false},"excerpt":{"rendered":"<p>Remi GAUCHOUX a le plaisir d&#8217;animer pour le compte de l&#8217;AFCROs la table ronde 1 d\u00e9di\u00e9e aux biotechs et medtechs <\/p>\n","protected":false},"author":15,"featured_media":9670,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","inline_featured_image":false,"_uag_custom_page_level_css":"","kk_blocks_editor_width":"","_kiokenblocks_attr":"","_kiokenblocks_dimensions":"","footnotes":""},"categories":[92],"tags":[],"class_list":["post-9676","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false],"thumbnail":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200-128x88.png",128,88,true],"medium":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200-300x150.png",300,150,true],"medium_large":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false],"large":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false],"1536x1536":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false],"2048x2048":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false],"post-thumbnail":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false],"wpm_taille_1":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200-364x200.png",364,200,true],"wpm_taille_slider":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200-240x145.png",240,145,true],"gform-image-choice-sm":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",300,150,false],"gform-image-choice-md":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false],"gform-image-choice-lg":["https:\/\/www.icta.fr\/wp-content\/uploads\/jrc2024_400x200.png",400,200,false]},"uagb_author_info":{"display_name":"Manon ROBERT","author_link":"https:\/\/www.icta.fr\/fr\/author\/mrobert-icta21\/"},"uagb_comment_info":0,"uagb_excerpt":"Remi GAUCHOUX a le plaisir d'animer pour le compte de l'AFCROs la table ronde 1 d\u00e9di\u00e9e aux biotechs et medtechs","_links":{"self":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/posts\/9676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/comments?post=9676"}],"version-history":[{"count":9,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/posts\/9676\/revisions"}],"predecessor-version":[{"id":9781,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/posts\/9676\/revisions\/9781"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/media\/9670"}],"wp:attachment":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/media?parent=9676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/categories?post=9676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/tags?post=9676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}